Home > Oncology > ESMO 2021 > COVID-19 > Cancer patients more likely to die from COVID-19 when hospital admittance is required

Cancer patients more likely to die from COVID-19 when hospital admittance is required

Presented By
Dr Tom Drake, University of Edinburgh, UK
Conference
ESMO 2021
Results from prospective data of >20,000 hospitalised patients with (a history of) cancer and COVID-19 show that these patients are more likely to die from COVID-19 than non-cancer patients with COVID-19. To evaluate the influence of (a history of) cancer on the in-hospital outcomes of patients with COVID-19, the International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) WHO Clinical Characterisation Protocol (CCP) UK (ISRCTN66726260) has collected complete data from 195,000 COVID-19 patients in the UK from 17 January 2020 to 12 August 2021. A total of 15,250 of these patients had a history of cancer and 5,357 were on active treatment for cancer. In-hospital outcomes of patients with (a history of) cancer were compared to those patients with no history of cancer. Dr Tom Drake (University of Edinburgh, UK) presented the results [1]. Relative...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on